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The number of women newly diagnosed with 
b reast cancer in Croatia is over 2,500 a year. Despite 
advances in diagnostic methods and all forms of 
therapeutic methods, there is still no clear evidence 
of decline in breast cancer mortality. The female 
breast cancer death rate of almost 1,000 cases a year 
is nearly 40% of the total number of new cases.
The treatment of breast cancer patients has 
become a public health problem. A prerequisite to 
a successful treatment is progress in early diagno-
sis, which can only be achieved through the in-
volvement and eff ort of the whole society. First, 
there should be a good national screening pro-
gram. Although Croatia has one, the response is 
still insuffi  cient. Further, there should be a multi-
disciplinary and individual approach that would 
result in signifi cant improvement in treatment.
Due to the use of biotechnologies, impressive 
progress in understanding the biology of breast 
cancer has been made in the last decade. A num-
ber of molecular methods available today are ap-
plied to identify and use the biomarkers, develop 
new therapies, and assist in the diff erentiation be-
tween the patients requiring treatment in a very 
early phase of the disease from those who do not. 
New drugs and treatment protocols require con-
siderable funds for the best available treatment.
It is also necessary to determine a subgroup 
of patients with hereditary breast cancer. This 
identifi cation of patients enables an optimal treat-
ment, follow-up and prevention.
Only if these issues are properly addressed 
our main goal, reducing breast cancer mortality, 
can be achieved.
